TELO offering history
Every offering-related filing in Telomir Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 139 filings back to Apr 3, 2023.
| Date | Filing | What it means | |
|---|---|---|---|
| Apr 24, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 21, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 21, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 28, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 14, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 11, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 12, 2024 | 424B1 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
| Feb 12, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Feb 8, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 3, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 19, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 14, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 14, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
TELO offering FAQ
When did TELO last execute an offering?
Per SEC filings, Telomir Pharmaceuticals, Inc.'s most recent priced offering document is a 8-K filed 2026-04-24. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did TELO last announce or register an offering?
The most recent registration is a S-3 filed 2025-02-14. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.